Quantcast

Latest Ketones Stories

2014-12-06 16:21:24

Data presented from largest combination buprenorphine/naloxone opioid dependence trial ever conducted in the U.S. MORRISTOWN, N.J., Dec. 6, 2014 /PRNewswire/ -- Orexo US, Inc.

2014-12-04 08:29:29

Lightlake Therapeutics advances collaboration with NIDA for novel intranasal naloxone application to reverse opioid overdose LONDON, Dec.

2014-12-04 08:29:05

Pain Insights, Inc.

2014-12-03 08:33:09

WALTHAM, Massachusetts, December 3, 2014 /PRNewswire/ -- EarlySense [http://www.earlysense.com ](R), the market leader in contact free monitoring solutions announced today

2014-12-02 23:10:39

MarketReportsOnline.com adds "The US Chronic Pain Market - Focus on Opioids: Trends & Opportunities (2014-2019)" report to its research store. Dallas,

2014-11-25 08:29:42

SAN DIEGO, Nov. 25, 2014 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the US Patent and Trademark Office granted Arena U.S. Patent No.

2014-11-24 08:29:04

CEO to Review Key Achievements During 2014 and Upcoming Milestones for Chronic Pain Pipeline in 2015 NEW YORK, Nov. 24, 2014 /PRNewswire/ -- Relmada Therapeutics, Inc.

2014-11-21 08:26:55

- Patent for naltrexone SR formulation expected to extend Contrave protection to 2028 SAN DIEGO, Nov. 21, 2014 /PRNewswire/ -- Orexigen Therapeutics, Inc.


Word of the Day
dynamitard
  • A political dynamiter.
The word 'dynamitard' is related to 'dynamite', which comes from a Greek root meaning 'power' and was coined by Alfred Nobel.